Portal de Periódicos da CAPES

Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings

2021; Elsevier BV; Volume: 104; Linguagem: Inglês

10.1016/j.ijid.2020.12.087

1878-3511

Mentor Ali Ber Lucien, Michael F. Canarie, Paul E. Kilgore, Gladzdin Jean-Denis, Natael Fénélon, Manise Pierre, Mauricio Cerpa, Gérard Joseph, Gina Maki, Marcus Zervos, Patrick Dély, Jacques Boncy, Hatim Sati, Ana del Rı́o, Pilar Ramón-Pardo,

SARS-CoV-2 and COVID-19 Research

The dissemination of COVID-19 around the globe has been followed by an increased consumption of antibiotics. This is related to the concern for bacterial superinfection in COVID-19 patients. The identification of bacterial pathogens is challenging in low and middle income countries (LMIC), as there are no readily-available and cost-effective clinical or biological markers that can effectively discriminate between bacterial and viral infections. Fortunately, faced with the threat of COVID-19 spread, there has been a growing awareness of the importance of antimicrobial stewardship programs, as well as infection prevention and control measures that could help reduce the microbial load and hence circulation of pathogens, with a reduction in dissemination of antimicrobial resistance. These measures should be improved particularly in developing countries. Studies need to be conducted to evaluate the worldwide evolution of antimicrobial resistance during the COVID-19 pandemic, because pathogens do not respect borders. This issue takes on even greater importance in developing countries, where data on resistance patterns are scarce, conditions for infectious pathogen transmission are optimal, and treatment resources are suboptimal.